These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9248966)

  • 1. Therapeutic monitoring, the concentration-effect relationship and impact on the clinical efficacy of antibiotic agents.
    Dawson SJ; Reeves DS
    J Chemother; 1997 May; 9 Suppl 1():84-92. PubMed ID: 9248966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Monitoring of antibiotic treatment of patient with a severe bacterial infection].
    Aubert G; Carricajo A
    Ann Fr Anesth Reanim; 2004 Jul; 23(7):704-13. PubMed ID: 15324959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selecting antibiotics based on pharmacokinetic and pharmacodynamic principles.
    Klutman NE
    Pharm Pract Manag Q; 1996 Jul; 16(2):9-12. PubMed ID: 10161616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Choosing an antibiotic on the basis of pharmacodynamics.
    Craig WA
    Ear Nose Throat J; 1998 Jun; 77(6 Suppl):7-11; discussion 11-2. PubMed ID: 9674328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In nosocomial pneumonia, optimizing antibiotics other than aminoglycosides is a more important determinant of successful clinical outcome, and a better means of avoiding resistance.
    Schentag JJ; Birmingham MC; Paladino JA; Carr JR; Hyatt JM; Forrest A; Zimmer GS; Adelman MH; Cumbo TJ
    Semin Respir Infect; 1997 Dec; 12(4):278-93. PubMed ID: 9436955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring antibiotic therapy in the newborn infant.
    Craft JC
    Clin Perinatol; 1981 Jun; 8(2):263-72. PubMed ID: 7273587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The importance of pharmacodynamic properties in treatment of penicillin resistant Streptococcus pneumoniae.
    Knudsen JD
    Dan Med Bull; 2000 Nov; 47(5):313-27. PubMed ID: 11155659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Future in vitro and animal studies: development of pharmacokinetic and pharmacodynamic efficacy predictors for tissue-based antibiotics.
    Nightingale CH
    Pharmacotherapy; 2005 Dec; 25(12 Pt 2):146S-149S. PubMed ID: 16305285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic/pharmacodynamic relationships of antimicrobial drugs used in veterinary medicine.
    McKellar QA; Sanchez Bruni SF; Jones DG
    J Vet Pharmacol Ther; 2004 Dec; 27(6):503-14. PubMed ID: 15601444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of antibiotic dosing intervals from in vitro susceptibility, pharmacokinetics and post-antibiotic effect: theoretical considerations.
    Turnidge JD
    Scand J Infect Dis Suppl; 1990; 74():137-41. PubMed ID: 2097701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment options in odontogenic infection.
    Maestre-Vera JR
    Med Oral Patol Oral Cir Bucal; 2004; 9 Suppl():25-31; 19-24. PubMed ID: 15580134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential impact of quantitative susceptibility tests on the design of aminoglycoside dosing regimens.
    McCormack JP; Schentag JJ
    Drug Intell Clin Pharm; 1987 Feb; 21(2):187-92. PubMed ID: 3829911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrating pharmacokinetics, pharmacodynamics and pharmacogenomics to predict outcomes in antibacterial therapy.
    Gumbo T
    Curr Opin Drug Discov Devel; 2008 Jan; 11(1):32-42. PubMed ID: 18175265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological indices in antibiotic therapy.
    Barger A; Fuhst C; Wiedemann B
    J Antimicrob Chemother; 2003 Dec; 52(6):893-8. PubMed ID: 14613960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Doripenem monohydrate, a broad-spectrum carbapenem antibiotic.
    Matthews SJ; Lancaster JW
    Clin Ther; 2009 Jan; 31(1):42-63. PubMed ID: 19243706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antimicrobial susceptibility testing of bacteria isolated from animals: considerations concerning the predefinition of breakpoints from the clinical pharmacological viewpoint].
    Kietzmann M; Böttner A; Hafez HM; Kehrenberg C; Klarmann D; Krabisch P; Kühn T; Luhofer G; Richter A; Schwarz S; Traeder W; Waldmann KH; Wallmann J; Werckenthin C; ;
    Berl Munch Tierarztl Wochenschr; 2004; 117(3-4):81-7. PubMed ID: 15046455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacodynamics: relation to antimicrobial resistance.
    Rybak MJ
    Am J Infect Control; 2006 Jun; 34(5 Suppl 1):S38-45; discussion S64-73. PubMed ID: 16813981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro antibiotic sensitivity testing breakpoints and therapeutic activity in induced infections in animal models.
    Soriano F; Aguilar L; Ponte C
    J Chemother; 1997 May; 9 Suppl 1():36-46. PubMed ID: 9248961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quinolones in 2005: an update.
    Van Bambeke F; Michot JM; Van Eldere J; Tulkens PM
    Clin Microbiol Infect; 2005 Apr; 11(4):256-80. PubMed ID: 15760423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacotherapy and pharmacodynamics in the management of bacterial infection.
    Rotschafer JC; Zabinski RA; Walker KJ; Vance-Bryan K
    J Clin Pharmacol; 1992 Dec; 32(12):1083-8. PubMed ID: 1487545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.